» » ยป

Real hope for people with severe vision loss Regina SK

Andy Livingstone used to count fingers. He suffered from severe vision loss. It started with not being able to see small details in his house. Eventu ...

BMO Bank of Montreal
(306) 569-5640
1800 Scarth St
Regina, SK
Type
Branch with ABM

Scotiabank
(306) 780-1200
1980 11Th Avenue
Regina, SK
 
Scotiabank
(306) 780-1275
4110 Albert Street
Regina, SK
 
BMO Bank of Montreal
(306) 569-5733
305 Albert St N
Regina, SK
Type
Branch with ABM

Scotiabank
(306) 780-1220
3835 Sherwood Drive
Regina, SK
 
Scotiabank
(306) 780-1230
1504 Albert Street
Regina, SK
 
Scotiabank
(306) 780-1250
2907 13Th Avenue
Regina, SK
 
Scotiabank
(306) 780-1285
625 University Park Drive
Regina, SK
 
BMO Bank of Montreal
(306) 569-5720
2705 Gordon Rd
Regina, SK
Type
Branch with ABM

BMO Bank of Montreal
(306) 569-5725
1871 Victoria Ave. E
Regina, SK
Type
Branch with ABM

Real hope for people with severe vision loss

Provided By:

(NC)-Andy Livingstone used to count fingers. He suffered from severe vision loss. It started with not being able to see small details in his house. Eventually, he couldn't even recognize the people he knew.

Andy was diagnosed with a disease that attacks the central vision of the eye known as wet age-related macular degeneration (AMD); a disease that affects nearly 300,000 Canadians. There are two forms of AMD, wet and dry, wet AMD being the most severe. Wet AMD is a progressive disease that attacks the central vision of the eye, necessary for ordinary vision-related activities such as seeing faces, reading and driving. Until now having the disease meant severe central vision loss and possibly even blindness in a matter of weeks to months.

Andy tried other treatments which were only able to slow down the progression of the disease. For Andy and all other patients, the recent approval of Lucentis represents real hope for vision improvement. This treatment is the first one to show improvement in a patient's vision and quality of life, and it sets a new standard for people who are being treated for wet AMD.

Canadian patients living with wet AMD received a dose of good news in March when the Common Drug Review (CDR), Canada's national drug review process in charge of providing recommendations on which drugs should be covered under provincial drug plans, recommended that Lucentis should be added to the list of medications paid for by each province.

This news brings all Canadians living with wet AMD one step closer to having access to the first and only treatment clinically proven to help patients regain vision and restore their quality of life.

Ontario and Quebec have decided to fight against blindness by already adding Lucentis to their provincial drug plans. It is now up to other individual provinces and territories to make the final listing and coverage decisions.

"You can't put a price on regaining your vision and your quality of life", says Andy. "Mine has improved so much thanks to this unique treatment, I can't even put it into words."

If you have been diagnosed with wet AMD or you notice a sudden change in your vision such as blurring or a blank spot in your visual field, speak to your eye doctor about this new advance in the treatment of wet AMD. Early diagnosis gives you a better chance at preserving your vision.

Credit: www.newscanada.com